Notice of Meeting, 46961 [2019-19293]

Download as PDF Federal Register / Vol. 84, No. 173 / Friday, September 6, 2019 / Notices Telephone: (240) 276–2419, Email: matthew.aumen@samhsa.hhs.gov. DEPARTMENT OF HEALTH AND HUMAN SERVICES Charles P. LoDico, Chemist. Substance Abuse and Mental Health Services Administration [FR Doc. 2019–19293 Filed 9–5–19; 8:45 am] BILLING CODE 4162–20–P Notice of Meeting jspears on DSK3GMQ082PROD with NOTICES Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention’s (CSAP) Drug Testing Advisory Board (DTAB) will convene via web conference on September 25th, 2019, from 10:00 a.m. EDT to 4:00 p.m. EDT. The board will meet in closed-session on September 25th, 2019, from 10:00 a.m. EDT to 4:00 p.m. EDT to discuss confidential issues surrounding the proposed Mandatory Guidelines for Federal Workplace Drug Testing Programs (urine specimens, oral fluid, hair), studies from Johns Hopkins Behavioral and Pharmacology Research Unit (BPRU), future direction considering the Farm Bill, and potential recommendations to the Assistant Secretary for Mental Health and Substance Use regarding additional drugs that may be tested for in the future. Therefore, the meeting is closed to the public, as determined by the Assistant Secretary for Mental Health and Substance Use, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 10(d). Meeting registration information can be completed at https:// snacregister.samhsa.gov/ MeetingList.aspx. Web conference and call information will be sent after completing registration. Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees website, https://www.samhsa.gov/ about-us/advisory-councils/meetings or by contacting the Designated Federal Officer, Matthew Aumen. Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention, Drug Testing Advisory Board. Dates/Time/Type: September 25, 2019, from 10:00 a.m. to 4:00 p.m. EDT: CLOSED. Place: Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857. Contact: Matthew Aumen, Program Analyst, Center for Substance Abuse Prevention, 5600 Fishers Lane, Room 16E61A, Rockville, Maryland 20857, VerDate Sep<11>2014 17:46 Sep 05, 2019 Jkt 247001 DEPARTMENT OF HOMELAND SECURITY U.S. Citizenship and Immigration Services [OMB Control Number 1615–0079] 46961 (This is not a toll-free number; comments are not accepted via telephone message.). Please note contact information provided here is solely for questions regarding this notice. It is not for individual case status inquiries. Applicants seeking information about the status of their individual cases can check Case Status Online, available at the USCIS website at https:// www.uscis.gov, or call the USCIS Contact Center at (800) 375–5283; TTY (800) 767–1833. SUPPLEMENTARY INFORMATION: Comments Agency Information Collection Activities; Revision of a Currently Approved Collection: Application for Replacement/Initial Nonimmigrant Arrival-Departure Document U.S. Citizenship and Immigration Services, Department of Homeland Security. ACTION: 30-Day notice. AGENCY: The Department of Homeland Security (DHS), U.S. Citizenship and Immigration Services (USCIS) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995. The purpose of this notice is to allow an additional 30 days for public comments. DATES: The purpose of this notice is to allow an additional 30 days for public comments. Comments are encouraged and will be accepted until October 7, 2019. SUMMARY: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, must be directed to the OMB USCIS Desk Officer via email at dhsdeskofficer@ omb.eop.gov. All submissions received must include the agency name and the OMB Control Number 1615–0079 in the subject line. You may wish to consider limiting the amount of personal information that you provide in any voluntary submission you make. For additional information please read the Privacy Act notice that is available via the link in the footer of https://www.regulations.gov. FOR FURTHER INFORMATION CONTACT: USCIS, Office of Policy and Strategy, Regulatory Coordination Division, Samantha Deshommes, Chief, 20 Massachusetts Avenue NW, Washington, DC 20529–2140, Telephone number (202) 272–8377 ADDRESSES: PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 The information collection notice was previously published in the Federal Register on June 6, 2019, at 84 FR 26422, allowing for a 60-day public comment period. USCIS did receive two comments in connection with the 60day notice. You may access the information collection instrument with instructions, or additional information by visiting the Federal eRulemaking Portal site at: https://www.regulations.gov and enter USCIS–2007–0011 in the search box. Written comments and suggestions from the public and affected agencies should address one or more of the following four points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection: (1) Type of Information Collection Request: Revision of a Currently Approved Collection. (2) Title of the Form/Collection: Application for Replacement/Initial Nonimmigrant Arrival-Departure Document. E:\FR\FM\06SEN1.SGM 06SEN1

Agencies

[Federal Register Volume 84, Number 173 (Friday, September 6, 2019)]
[Notices]
[Page 46961]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19293]



[[Page 46961]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory 
Board (DTAB) will convene via web conference on September 25th, 2019, 
from 10:00 a.m. EDT to 4:00 p.m. EDT.
    The board will meet in closed-session on September 25th, 2019, from 
10:00 a.m. EDT to 4:00 p.m. EDT to discuss confidential issues 
surrounding the proposed Mandatory Guidelines for Federal Workplace 
Drug Testing Programs (urine specimens, oral fluid, hair), studies from 
Johns Hopkins Behavioral and Pharmacology Research Unit (BPRU), future 
direction considering the Farm Bill, and potential recommendations to 
the Assistant Secretary for Mental Health and Substance Use regarding 
additional drugs that may be tested for in the future. Therefore, the 
meeting is closed to the public, as determined by the Assistant 
Secretary for Mental Health and Substance Use, SAMHSA, in accordance 
with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 
10(d).
    Meeting registration information can be completed at https://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call 
information will be sent after completing registration. Meeting 
information and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Designated Federal 
Officer, Matthew Aumen.

    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: September 25, 2019, from 10:00 a.m. to 4:00 
p.m. EDT: CLOSED.
    Place: Substance Abuse and Mental Health Services 
Administration, 5600 Fishers Lane, Rockville, MD 20857.
    Contact: Matthew Aumen, Program Analyst, Center for Substance 
Abuse Prevention, 5600 Fishers Lane, Room 16E61A, Rockville, 
Maryland 20857, Telephone: (240) 276-2419, Email: 
[email protected].

Charles P. LoDico,
Chemist.
[FR Doc. 2019-19293 Filed 9-5-19; 8:45 am]
 BILLING CODE 4162-20-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.